XANTUS-EL: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Eastern Europe, Middle East, Africa and Latin America-Reference-Cited by-同舟云学术

XANTUS-EL: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Eastern Europe, Middle East, Africa and Latin America

Published:2018-12 Issue:4 Volume:70 Page:307-313
ISSN:1110-2608
Container-title:The Egyptian Heart Journal
language:en
Short-container-title:The Egyptian Heart Journal

Author:

Martínez Carlos Arturo Areán,Lanas Fernando,Radaideh Ghazi,Kharabsheh Suleiman M.,Lambelet Marc,Viaud Marco Antonio Lavagnino,Ziadeh Naser Samih,Turpie Alexander G.G.

Funder

Bayer AG

Janssen Scientific Affairs, LLC

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study;Chugh;Circulation,2014

2. Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF;Bassand;Eur Heart J,2016

3. Epidemiology of atrial fibrillation: European perspective;Zoni-Berisso;Clin Epidemiol,2014

4. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials;Ruff;Lancet,2014

5. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society;January;Circulation,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS);European Heart Journal;2024-08-30

2. Causes of death in patients with atrial fibrillation anticoagulated with rivaroxaban: a pooled analysis of XANTUS;Europace;2024-06-29

3. The Atrial FibriLlatiOn (FLOW-AF) Registry in the Middle East and North Africa: Patient Characteristics, Treatment Patterns and Outcomes;Advances in Therapy;2024-05-27

4. Evidence-based Management of Major Bleeding in Patients Receiving Direct Oral Anticoagulants: An Updated Narrative Review on the Role of Specific Reversal Agents;Journal of Cardiovascular Pharmacology and Therapeutics;2023-01

5. Comparative Effectiveness and Safety of Rivaroxaban and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in an Omani Tertiary Care Hospital;The Open Cardiovascular Medicine Journal;2022-06-20